CDK4 is an essential insulin effector in adipocytes.

Lagarrigue S, Lopez-Mejia IC, Denechaud PD, Escoté X, Castillo-Armengol J, Jimenez V, Chavey C, Giralt A, Lai Q, Zhang L, Martinez-Carreres L, Delacuisine B, Annicotte JS, Blanchet E, Huré S, Abella A, Tinahones FJ, Vendrell J, Dubus P, Bosch F, Kahn CR, Fajas L

Open source

DOI: 10.1172/jci81480
Published: 2016 Jan
Container: The Journal of clinical investigation
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 4/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
cautionRetraction Watch correction: 1 correction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci81480,
  title = {CDK4 is an essential insulin effector in adipocytes.},
  author = {Lagarrigue S and Lopez-Mejia IC and Denechaud PD and Escoté X and Castillo-Armengol J and Jimenez V and Chavey C and Giralt A and Lai Q and Zhang L and Martinez-Carreres L and Delacuisine B and Annicotte JS and Blanchet E and Huré S and Abella A and Tinahones FJ and Vendrell J and Dubus P and Bosch F and Kahn CR and Fajas L},
  year = {2016},
  journal = {The Journal of clinical investigation},
  doi = {10.1172/jci81480},
  url = {https://doi.org/10.1172/jci81480}
}

RIS

TY  - JOUR
TI  - CDK4 is an essential insulin effector in adipocytes.
AU  - Lagarrigue S
AU  - Lopez-Mejia IC
AU  - Denechaud PD
AU  - Escoté X
AU  - Castillo-Armengol J
AU  - Jimenez V
AU  - Chavey C
AU  - Giralt A
AU  - Lai Q
AU  - Zhang L
AU  - Martinez-Carreres L
AU  - Delacuisine B
AU  - Annicotte JS
AU  - Blanchet E
AU  - Huré S
AU  - Abella A
AU  - Tinahones FJ
AU  - Vendrell J
AU  - Dubus P
AU  - Bosch F
AU  - Kahn CR
AU  - Fajas L
PY  - 2016
JO  - The Journal of clinical investigation
DO  - 10.1172/jci81480
UR  - https://doi.org/10.1172/jci81480
ER  -

APA

S, L., IC, L., PD, D., X, E., J, C., V, J., C, C., A, G., Q, L., L, Z., L, M., B, D., JS, A., E, B., S, H., A, A., FJ, T., J, V., P, D., F, B., CR, K., & L, F. (2016). CDK4 is an essential insulin effector in adipocytes.. The Journal of clinical investigation. https://doi.org/10.1172/jci81480

Source records

pubmed · retrieved 2026-09-24T19:02:00.023Z
europe-pmc · retrieved 2026-09-24T19:02:00.045Z
hal · retrieved 2026-09-24T19:02:00.081Z